Breaking News
Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate, Shares Surge 11.8%
Dyne Therapeutics narrows Q4 loss to $0.73/share vs $0.76 estimate, shares jump 11.8% on improving trajectory and $893M cash position.